Course Provider
While Maastricht University may not have a single dedicated psychedelic research group, various researchers at the university are investigating the effects of psychedelics. Early research exploring psychedelics at Maastricht focused on the dangers of MDMA. Now, research into the effects of microdosing is being led by Dr Kim Kuypers. Other research ongoing at the university is investigating cannabis as well as novel psychoactive substances (NPS). Maastricht is collaborating on research with the Beckley Foundation as well as Silo Pharma.
Maastricht University is not, from the evidence available, a dedicated psychedelic training provider in the way some specialist institutes are. Rather, it is a serious research university with a well-established psychopharmacology and neuropsychology base, and its psychedelic work sits inside that broader scientific frame, especially around microdosing, psilocybin, MDMA and related substance effects. It will likely suit people looking for academically grounded study rather than practitioner training; the strongest lineage here is research-led, with Dr Kim Kuypers prominently associated with the area. The reputation signal is more 'credible university research environment' than 'certificate brand'.
Best for students, researchers, and clinicians who want an academic grounding in psychedelic science within a wider psychopharmacology curriculum. It is less obviously aimed at people seeking a standalone facilitator or therapist qualification.
No dedicated psychedelic course prerequisites were found on the public sources reviewed. For the university’s taught degree programmes, standard university entry requirements apply; one research master route in Drug Development and Neurohealth is part of the broader educational offer.
Maastricht University states that all of its bachelor’s and master’s programmes have been approved by the NVAO, the Dutch-Flemish Accreditation Organisation. No source reviewed showed a dedicated psychedelic certificate, CME, CE credit, or separate accreditation for a psychedelics-specific training.
No psychedelics-specific tuition or pricing was found. The public sources reviewed indicate that psychedelic content appears within existing university teaching and research programmes, rather than as a separately priced standalone course.
Learners appear to gain academic knowledge of psychedelics, microdosing, psychopharmacology, and drug effects on cognition and behaviour, rather than a distinct external credential. In programme contexts, outcomes are likely to be research literacy, methodological understanding, and pathways into neuroscience, psychopharmacology, or related postgraduate study.
Linked Courses
1
Active Listings
1
Primary Formats
Live Classes
Programs linked directly to this provider in the Blossom course dataset.
Reference points selected from shared training modalities, learner audience, level, delivery format, pricing, and location.